(Received for publication September 1, 1977) In a previous paper1) we reported the synthe- Table 1 .
The activity of 4'-deoxykanamycin B against 6 strains of aminoglycoside-sensitive organisms was nearly the same as that of kanamycin B, while 4'-deoxykanamycin A was about one-half as active as kanamycin A against these organisms. Two strains of P. aeruginosa which did not produce an aminoglycoside-inactivating enzyme showed greater sensitivity to 4'-deoxykanamycins than to the parent antibiotics. It has been shown" that 4'-deoxykanamycin A inhibits aminoglycoside-resistant organisms which produce aminoglycoside-3'-phosphotransferase II [APH(2')-II]. 4'-Deoxykanamycin B also inhibits APH(2')-II-producing organisms though to a lesser extent than 4'-deoxykanamycin A.
Both 4'-deoxykanamycins A and B inhibited Escherichia coli NR79/W677 which produces aminoglycoside-6'-acetyltransferase-I
[AAC(6')--I] , although the organism was more susceptible to 4'-deoxykanamycin A than 4'-deoxykanamycin B. Two pseudomonal strains which produced AAC(6')-III or IV were not inhibited by 4'-deoxykanamycins A and B. YAGISAWA et al. 8 observed that 4'-deoxykanamycin A was less readily acetylated than kanamycin A by P. aeruginosa GN315, an AAC(6')-IV-producer.
Two strains of S. aureus and one strain each of S. epidermidis and B. brevis, all of which have been reported to produce aminoglycoside-4'-adenylyltransferase [ANT(4')]2,3,4), showed varied susceptibility to 4'-deoxykanamycins A and B. 4'-Deoxykanamycin B inhibited these organisms at 3.1 mcg/ml except for one staphylococcal strain, A22054, which was inhibited only at 50 mcg/ml. The activity of 4'-deoxykanamycin A against this group of resistant organisms was generally lower and more variable than that of 4'-deoxykanamycin B. The degree and nature of sensitivity of these organisms suggest a possible involvement of resistant mechanisms other than 4'-adenylylation that can affect the 4'-deoxygenated kanamycin derivatives.
